Correlation between clinical features and prognosis of local recurrence after breast-conserving therapy

被引：1

作者：

Shin E. ^{[1
]}

Takatsuka Y. ^{[2
]}

Okamura Y. ^{[3
]}

Nishisho I. ^{[1
]}

Kawahara K. ^{[4
]}

Kurata A. ^{[4
]}

Kikkawa N. ^{[1
]}

机构：

[1] Department of Surgery, Osaka National Hospital, Chuo-ku, Osaka 540-0006

[2] Department of Surgery, Kansairosai Hospital, Osaka

[3] Department of Surgery, Torigata Hospital, Osaka

[4] Department of Clinical Laboratory, Osaka National Hospital, Osaka

来源：

International Journal of Clinical Oncology | 2000年 / 5卷 / 1期

关键词：

Breast cancer; Breast-conserving therapy; Local recurrence; Prognosis;

D O I：

10.1007/s101470050005

中图分类号：

学科分类号：

摘要：

Background. In patients with early stage breast cancer who have breast- conserving therapy (BCT), the impact of local recurrence on the risk of distant metastasis is still controversial. Local recurrence after BCT is an uncommon event, so it is impossible to determine a standard treatment method by a clinical trial because not enough patients can be enrolled. Methods. Between February 1988 and December 1997, 399 patients with clinical stage I and II breast cancer underwent BCT in our department. Of these 399 patients, 22 developed local recurrence during this period. To assess the relationship between their clinical characteristics and prognosis, we performed a retrospective review of these 22 patients. Results. The 5-year overall survival rate after local recurrence was 66.7%. All four patients who had cutaneous or inflammatory type recurrence developed distant metastasis after salvage treatment. Of three patients with multiple recurrence, two developed disseminated disease after salvage treatment. Two of four patients treated by repeat lumpectomy developed further local recurrence after salvage lumpectomy. Conclusion. To improve prognosis in patients with multiple, cutaneous, or inflammatory recurrence, aggressive adjuvant systemic therapy may be required after salvage surgery.

引用

页码：22 / 28

页数：6

共 21 条

[1] Takashima S., Doihara H., Mandai K., Et al., The breast cancer patient with the unique local recurrent findings after breast-conserving operation. Report of an autopsy case, Nyugan No Rinsho (Jpn J Breast Cancer), 8, pp. 303-309, (1993)
[2] Motomura K., Koyama H., Noguchi S., Et al., Six cases of local recurrence following breast conserving therapy for breast cancer, Nihon Gan Tiryou Gakkaisi (J Jpn Soc Cancer Ther), 29, pp. 1782-1786, (1994)
[3] Shin E., Takatsuka Y., Kadota M., Et al., A case of local recurrence similar to inflammatory breast cancer after breast-conserving surgery, Nyugan No Rinsho (Jpn J Breast Cancer), 10, pp. 575-579, (1995)
[4] Takahashi M., Takahashi H., Suzuki H., Et al., Local recurrence after conservative surgery for breast cancer, Breast Cancer, 3, pp. 135-139, (1996)
[5] Okano K., Fukutomi T., Tsuda H., Et al., Local recurrence after conservative surgery without postoperative radiation of pure tubular carcinoma of the breast: A case report with reference to multifocality of tubular carcinoma, Breast Cancer, 5, pp. 201-204, (1998)
[6] Noguchi S., Koyama H., Kasugai T., Et al., A case-control study on risk factors for local recurrences or distant metastases in breast cancer patients treated with breast-conserving surgery, Oncology, 54, pp. 468-474, (1997)
[7] Noguchi S., Koyama H., Kasugai T., Et al., The possible prognostic significance of p53 immunostaining status of the primary tumor in patients developing local recurrence after breast-conserving surgery, Oncology, 55, pp. 450-455, (1998)
[8] Nishimura R., Koyama H., Kasumi F., Et al., A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgery, Oncology, 55, pp. 391-399, (1998)
[9] Shin E., Takatsuka Y., Okamura Y., Et al., A retrospective study of breast cancer patients treated with quadrantectomy without radiation therapy, Breast Cancer, 6, pp. 109-116, (1999)
[10] Shin E., Takatsuka Y., Okamura Y., Et al., Risk factors for local recurrence after breast-conserving therapy, Int J Clin Oncol, 4, pp. 230-235, (1999)

← 1 2 3 →